Lungen Lu

468 total citations
7 papers, 386 citations indexed

About

Lungen Lu is a scholar working on Hepatology, Epidemiology and Pharmacology. According to data from OpenAlex, Lungen Lu has authored 7 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hepatology, 2 papers in Epidemiology and 2 papers in Pharmacology. Recurrent topics in Lungen Lu's work include Liver physiology and pathology (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Phytochemistry and Bioactive Compounds (1 paper). Lungen Lu is often cited by papers focused on Liver physiology and pathology (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Phytochemistry and Bioactive Compounds (1 paper). Lungen Lu collaborates with scholars based in China and Spain. Lungen Lu's co-authors include Fei Pan, Zheng Zhang, Daxiang Cui, Kan Wang, Chunlei Zhang, Yixia Zhang, Shangli Cheng, Di Chen, Jesús M. de la Fuente and Yun‐Sheng Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and The FASEB Journal.

In The Last Decade

Lungen Lu

7 papers receiving 384 citations

Peers

Lungen Lu
Ximo Wang China
Bumjun Kim United States
Guiqi Qin China
Xuping Wu China
Dan Casciano United States
Ximo Wang China
Lungen Lu
Citations per year, relative to Lungen Lu Lungen Lu (= 1×) peers Ximo Wang

Countries citing papers authored by Lungen Lu

Since Specialization
Citations

This map shows the geographic impact of Lungen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lungen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lungen Lu more than expected).

Fields of papers citing papers by Lungen Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lungen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lungen Lu. The network helps show where Lungen Lu may publish in the future.

Co-authorship network of co-authors of Lungen Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Lungen Lu. A scholar is included among the top collaborators of Lungen Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lungen Lu. Lungen Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Gillessen, Anton, Francesco Angelico, Jun Chen, et al.. (2022). Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations. SHILAP Revista de lepidopterología. 1(5). 882–893. 7 indexed citations
2.
Guo, Yuecheng, Xianjun Xu, Hui Dong, et al.. (2022). Loss of YB-1 alleviates liver fibrosis by suppressing epithelial-mesenchymal transition in hepatic progenitor cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(11). 166510–166510. 4 indexed citations
3.
Gu, Tianyi, Bo Shen, Binghang Li, et al.. (2021). miR‐30c inhibits angiogenesis by targeting delta‐like ligand 4 in liver sinusoidal endothelial cell to attenuate liver fibrosis. The FASEB Journal. 35(5). e21571–e21571. 16 indexed citations
4.
Cai, Xiaobo, Zhenghong Li, Qidi Zhang, et al.. (2018). CXCL6‐EGFR‐induced Kupffer cells secrete TGF‐β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C‐MYC/EZH2 pathway in liver fibrosis. Journal of Cellular and Molecular Medicine. 22(10). 5050–5061. 86 indexed citations
5.
Chen, Yun‐Sheng, Yixia Zhang, Fei Pan, et al.. (2016). Breath Analysis Based on Surface-Enhanced Raman Scattering Sensors Distinguishes Early and Advanced Gastric Cancer Patients from Healthy Persons. ACS Nano. 10(9). 8169–8179. 248 indexed citations
6.
Shen, Min, et al.. (2007). Phase I Safety and Pharmacokinetic Study of Magnesium Isoglycyrrhizinate After Single and Multiple Intravenous Doses in Chinese Healthy Volunteers. The Journal of Clinical Pharmacology. 47(6). 767–773. 21 indexed citations
7.
Lu, Lungen. (2004). [Pathogenesis of hepatic encephalopathy].. PubMed. 12(5). 304–304. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026